Share this article
Share this article
NEW YORK, Dec. 15, 2020 /PRNewswire/ As per the World Health Organization (WHO), in 2018, 2.09 million cases, 2.08 million cases, 1.80 million cases, 1.28 million cases, 1.04 million cases, and 1.03 million cases of lung cancer, breast cancer, colorectal cancer, prostate cancer, skin cancer, and stomach cancer, respectively, were detected. Due to this factor, the global photoacoustic imaging market will likely witness a healthy 20.3% CAGR during 2020–2030, to grow to $279.3 million by 2030 from $39.8 million in 2019, says P&S Intelligence.
Photoacoustic imaging is used to look at the internal human anatomy, wherein the pictures are formed based on how much laser radiation is being absorbed by tissues or the contrast agent injected. In this regard, the photoacoustic imaging market is also being driven by the increasing prevalence of respiratory and cardiovascular diseases (CVDs). The WHO estimates the annual death count of CVDs at 17.9 mil